My best stocks almost never get a comment on HC. Have a look at the DTL forum, for example.By contrast, the worst stocks I have ever touched have all had a maelstrom of conflicting and emotional commentary on HC.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
